77 related articles for article (PubMed ID: 3085355)
1. Effect of Piriprost, a 5-lipoxygenase inhibitor, on leukocyte accumulation during thioglycollate-induced acute inflammation.
Lawson CF; Smith HW; Fitzpatrick FA
Wien Klin Wochenschr; 1986 Feb; 98(4):110-3. PubMed ID: 3085355
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human neutrophil arachidonate 5-lipoxygenase by 6,9-deepoxy-6,9-(phenylimino)-delta 6,8-prostaglandin I1 (U-60257).
Sun FF; McGuire JC
Prostaglandins; 1983 Aug; 26(2):211-21. PubMed ID: 6417727
[TBL] [Abstract][Full Text] [Related]
3. Effect of the 5-lipoxygenase inhibitor piriprost on superoxide production by human neutrophils.
Flament J; Schandene L; Boeynaems JM
Prostaglandins Leukot Essent Fatty Acids; 1988 Dec; 34(3):175-80. PubMed ID: 2851839
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the leukotriene synthetase of rat basophil leukemia cells by diethylcarbamazine, and synergism between diethylcarbamazine and piriprost, a 5-lipoxygenase inhibitor.
Bach MK; Brashler JR
Biochem Pharmacol; 1986 Feb; 35(3):425-33. PubMed ID: 3004501
[TBL] [Abstract][Full Text] [Related]
5. [Regulatory mechanisms of erythropoiesis by leukocytes in inflammation].
Klimenko MO; Shevchenko OM
Fiziol Zh (1994); 2000; 46(5):41-6. PubMed ID: 11269852
[TBL] [Abstract][Full Text] [Related]
6. In vivo anti-allergic and anti-inflammatory effects of drugs that inhibit lipoxygenase activity in vitro.
Etienne A; Soulard C; Touvay C; Clostre F; Braquet P
Int J Tissue React; 1985; 7(6):459-62. PubMed ID: 3936815
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte stimulation of intimal lesion formation is inhibited by treatment with diclofenac sodium and dexamethasone.
Prescott MF; McBride CK; Venturini CM; Gerhardt SC
J Cardiovasc Pharmacol; 1989; 14 Suppl 6():S76-81. PubMed ID: 2478829
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.
Kirchner T; Argentieri DC; Barbone AG; Singer M; Steber M; Ansell J; Beers SA; Wachter MP; Wu W; Malloy E; Stewart A; Ritchie DM
J Pharmacol Exp Ther; 1997 Aug; 282(2):1094-101. PubMed ID: 9262379
[TBL] [Abstract][Full Text] [Related]
9. Thioglycollate peritonitis in mice lacking C5, 5-lipoxygenase, or p47(phox): complement, leukotrienes, and reactive oxidants in acute inflammation.
Segal BH; Kuhns DB; Ding L; Gallin JI; Holland SM
J Leukoc Biol; 2002 Mar; 71(3):410-6. PubMed ID: 11867678
[TBL] [Abstract][Full Text] [Related]
10. [The role of leukocytes in the increased vessel permeability in inflammation].
Klimenko NA; Pavlova EA
Biull Eksp Biol Med; 1999 Aug; 127(8):165-7. PubMed ID: 11188736
[No Abstract] [Full Text] [Related]
11. Inhibition of rat liver glutathione S-transferases by piriprost: kinetics of the inhibition and preliminary evidence that piriprost may be a poor alternative substrate for these enzymes.
Bach MK; O'Brien J; Brashler JR; Johnson MA; Morton DR
Res Commun Chem Pathol Pharmacol; 1985 Sep; 49(3):361-86. PubMed ID: 3903894
[TBL] [Abstract][Full Text] [Related]
12. [Effect of dexamethasone on mast cell reaction in inflammation].
Klymenko MO; Kozyrieva HF
Fiziol Zh (1994); 2002; 48(3):29-33. PubMed ID: 12125281
[TBL] [Abstract][Full Text] [Related]
13. Experiments on the mode of action of piriprost (U-60,257), an inhibitor of leukotriene formation in cloned mouse mast cells and in rat basophil leukemia cells.
Bach MK; Brashler JR; White GJ; Galli SJ
Biochem Pharmacol; 1987 May; 36(9):1461-6. PubMed ID: 3107573
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of anti-inflammatory action of dexamethasone: blockade by hydrocortisone mesylate and actinomycin D of the inhibitory effect of dexamethasone on leukocyte infiltration in inflammatory sites.
Tsurufuji S; Kurihara A; Ojima F
J Pharmacol Exp Ther; 1984 Apr; 229(1):237-43. PubMed ID: 6707940
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the ocular anti-inflammatory activity of steroidal and nonsteroidal compounds in the rat.
Bhattacherjee P; Williams RN; Eakins KE
Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1143-6. PubMed ID: 6874278
[TBL] [Abstract][Full Text] [Related]
16. Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization.
Castro MR; Lutz D; Edelman JL
Exp Eye Res; 2004 Aug; 79(2):275-85. PubMed ID: 15325574
[TBL] [Abstract][Full Text] [Related]
17. 6,9-deepoxy-6,9,-(phenylimino)-delta 6,8-prostaglandin I1, (U-60,257), a new inhibitor of leukotriene C and D synthesis: in vitro studies.
Bach MK; Brashler JR; Smith HW; Fitzpatrick FA; Sun FF; McGuire JC
Prostaglandins; 1982 May; 23(5):759-71. PubMed ID: 6812165
[TBL] [Abstract][Full Text] [Related]
18. [The effect of dexamethasone on the reactions of the blood system in inflammation].
Klymenko MO; Shevchenko OM
Fiziol Zh (1994); 1998; 44(5-6):73-9. PubMed ID: 9866028
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of the dual inhibitor of cyclooxygenase and 5-lipoxygenase 3-hydroxy-5-trifluoromethyl-N-(2-(2-thienyl)-2-phenyl-ethenyl)-benzo (b)thiophene-2-carboxamide.
Bailey PJ; Dallob AL; Allison DL; Anderson RL; Bach T; Durette PL; Hand KM; Hopple SL; Luell S; Meurer R
Arzneimittelforschung; 1988 Mar; 38(3):372-8. PubMed ID: 3132928
[TBL] [Abstract][Full Text] [Related]
20. The anti-inflammatory effects of ZLJ-6, a novel dual cyclooxygenase/5-lipoxygenase inhibitor.
Li L; Ji H; Sheng L; Zhang Y; Lai Y; Chen X
Eur J Pharmacol; 2009 Apr; 607(1-3):244-50. PubMed ID: 19243697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
